TY - JOUR
T1 - Noradrenaline Modulates Visual Perception and Late Visually Evoked Activity
AU - Gelbard-Sagiv, Hagar
AU - Magidov, Efrat
AU - Sharon, Haggai
AU - Hendler, Talma
AU - Nir, Yuval
N1 - Funding Information: We thank Rafael Malach, Inna Slutski, Liad Mudrik, and Amit Marmelshtein for helpful discussions and comments on the manuscript; Nitsan Censor, Dominique Lamy, Leon Deouell, Sharon Gilaie-Dotan, Shlomo Schrader, Galit Yovel, Niv Reggev, Marcello Massimini, Lucia Meloni, and Shlomit Yuval-Greenberg for suggestions; Avi Weizman and Moshe Rechavi for help with drug choice; Lilac Meltzer for help with data acquisition; Michal Harel and Aya Ben-Yakov for help with MRI data analysis; Francesca Strappini and Ilan Dinstein for help with retinotopy paradigms; and Shimrit Solnik, Guy Gurevich, Noam Goldway, and Orly Elchadif for help with experimental setup at the Functional Neurophysiology Lab, Sagol Brain Institute, Sourasky Medical Center, Tel Aviv. This work was supported by the European Union’s Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) IF-EF-RI-659759 grant (H.G.-S.), the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant no. 51/11 ; Y.N.), the FP7 Marie Curie Career Integration Grant ( PCIG14-GA-2013-630974 ; Y.N.), ISF grant 1326/15 (Y.N.), the Adelis Prize in Neuroscience (Y.N.), and the Marguerite Stolz Research Fellowship Fund (Y.N.). Funding Information: We thank Rafael Malach, Inna Slutski, Liad Mudrik, and Amit Marmelshtein for helpful discussions and comments on the manuscript; Nitsan Censor, Dominique Lamy, Leon Deouell, Sharon Gilaie-Dotan, Shlomo Schrader, Galit Yovel, Niv Reggev, Marcello Massimini, Lucia Meloni, and Shlomit Yuval-Greenberg for suggestions; Avi Weizman and Moshe Rechavi for help with drug choice; Lilac Meltzer for help with data acquisition; Michal Harel and Aya Ben-Yakov for help with MRI data analysis; Francesca Strappini and Ilan Dinstein for help with retinotopy paradigms; and Shimrit Solnik, Guy Gurevich, Noam Goldway, and Orly Elchadif for help with experimental setup at the Functional Neurophysiology Lab, Sagol Brain Institute, Sourasky Medical Center, Tel Aviv. This work was supported by the European Union's Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) IF-EF-RI-659759 grant (H.G.-S.), the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant no. 51/11; Y.N.), the FP7 Marie Curie Career Integration Grant (PCIG14-GA-2013-630974; Y.N.), ISF grant 1326/15 (Y.N.), the Adelis Prize in Neuroscience (Y.N.), and the Marguerite Stolz Research Fellowship Fund (Y.N.). Funding Information: We thank Rafael Malach, Inna Slutski, Liad Mudrik, and Amit Marmelshtein for helpful discussions and comments on the manuscript; Nitsan Censor, Dominique Lamy, Leon Deouell, Sharon Gilaie-Dotan, Shlomo Schrader, Galit Yovel, Niv Reggev, Marcello Massimini, Lucia Meloni, and Shlomit Yuval-Greenberg for suggestions; Avi Weizman and Moshe Rechavi for help with drug choice; Lilac Meltzer for help with data acquisition; Michal Harel and Aya Ben-Yakov for help with MRI data analysis; Francesca Strappini and Ilan Dinstein for help with retinotopy paradigms; and Shimrit Solnik, Guy Gurevich, Noam Goldway, and Orly Elchadif for help with experimental setup at the Functional Neurophysiology Lab, Sagol Brain Institute, Sourasky Medical Center, Tel Aviv. This work was supported by the European Union's Horizon 2020 Marie Sk?odowska-Curie Actions (MSCA) IF-EF-RI-659759 grant (H.G.-S.), the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (grant no. 51/11; Y.N.), the FP7 Marie Curie Career Integration Grant (PCIG14-GA-2013-630974; Y.N.), ISF grant 1326/15 (Y.N.), the Adelis Prize in Neuroscience (Y.N.), and the Marguerite Stolz Research Fellowship Fund (Y.N.). Publisher Copyright: © 2018 Elsevier Ltd
PY - 2018/7/23
Y1 - 2018/7/23
N2 - An identical sensory stimulus may or may not be incorporated into perceptual experience, depending on the behavioral and cognitive state of the organism. What determines whether a sensory stimulus will be perceived? While different behavioral and cognitive states may share a similar profile of electrophysiology, metabolism, and early sensory responses, neuromodulation is often different and therefore may constitute a key mechanism enabling perceptual awareness. Specifically, noradrenaline improves sensory responses, correlates with orienting toward behaviorally relevant stimuli, and is markedly reduced during sleep, while experience is largely “disconnected” from external events. Despite correlative evidence hinting at a relationship between noradrenaline and perception, causal evidence remains absent. Here, we pharmacologically down- and upregulated noradrenaline signaling in healthy volunteers using clonidine and reboxetine in double-blind placebo-controlled experiments, testing the effects on perceptual abilities and visually evoked electroencephalography (EEG) and fMRI responses. We found that detection sensitivity, discrimination accuracy, and subjective visibility change in accordance with noradrenaline (NE) levels, whereas decision bias (criterion) is not affected. Similarly, noradrenaline increases the consistency of EEG visually evoked potentials, while lower noradrenaline levels delay response components around 200 ms. Furthermore, blood-oxygen-level-dependent (BOLD) fMRI activations in high-order visual cortex selectively vary along with noradrenaline signaling. Taken together, these results point to noradrenaline as a key factor causally linking visual awareness to external world events. Video Abstract: [Figure presented] Gelbard-Sagiv, Magidov et al. pharmacologically down- and upregulated NE signaling while subjects performed visual detection and discrimination tasks. They demonstrate that NE modulates perceptual sensitivity and accuracy, as well as late visually evoked EEG and fMRI responses, suggesting a key enabling role for NE in perceptual awareness.
AB - An identical sensory stimulus may or may not be incorporated into perceptual experience, depending on the behavioral and cognitive state of the organism. What determines whether a sensory stimulus will be perceived? While different behavioral and cognitive states may share a similar profile of electrophysiology, metabolism, and early sensory responses, neuromodulation is often different and therefore may constitute a key mechanism enabling perceptual awareness. Specifically, noradrenaline improves sensory responses, correlates with orienting toward behaviorally relevant stimuli, and is markedly reduced during sleep, while experience is largely “disconnected” from external events. Despite correlative evidence hinting at a relationship between noradrenaline and perception, causal evidence remains absent. Here, we pharmacologically down- and upregulated noradrenaline signaling in healthy volunteers using clonidine and reboxetine in double-blind placebo-controlled experiments, testing the effects on perceptual abilities and visually evoked electroencephalography (EEG) and fMRI responses. We found that detection sensitivity, discrimination accuracy, and subjective visibility change in accordance with noradrenaline (NE) levels, whereas decision bias (criterion) is not affected. Similarly, noradrenaline increases the consistency of EEG visually evoked potentials, while lower noradrenaline levels delay response components around 200 ms. Furthermore, blood-oxygen-level-dependent (BOLD) fMRI activations in high-order visual cortex selectively vary along with noradrenaline signaling. Taken together, these results point to noradrenaline as a key factor causally linking visual awareness to external world events. Video Abstract: [Figure presented] Gelbard-Sagiv, Magidov et al. pharmacologically down- and upregulated NE signaling while subjects performed visual detection and discrimination tasks. They demonstrate that NE modulates perceptual sensitivity and accuracy, as well as late visually evoked EEG and fMRI responses, suggesting a key enabling role for NE in perceptual awareness.
KW - EEG
KW - Locus Coeruleus
KW - clonidine
KW - fMRI
KW - human
KW - neuromodulation
KW - noradrenaline
KW - norepinephrine
KW - perception
KW - reboxetine
KW - vision
UR - https://www.scopus.com/pages/publications/85049094587
U2 - 10.1016/j.cub.2018.05.051
DO - 10.1016/j.cub.2018.05.051
M3 - Article
SN - 0960-9822
VL - 28
SP - 2239-2249.e6
JO - Current Biology
JF - Current Biology
IS - 14
ER -